The use of ultrasound-enhancing agents (UEAs) in the practice of contrast echocardiography is now considered an essential component of a state-of-the-art echocardiography laboratory. Education on the appropriate use of UEAs to improve quantitative measurements of LV size and function, to detect regional dysfunction at rest and during stress, and to detect LV cavity abnormalities (thrombus, masses, hypertrophic cardiomyopathies, etc.) are necessary & their value to patient care needs to be reinforced. While didactic lectures are effective for teaching the impact of UEAs on patient care, the major clinical obstacle to the clinical adoption of contrast echocardiography is unfamiliarity with a variety of components. This IV access video allows for familiarity and learning so diagnostic imaging can be improved and patient care can be enhanced.
- Introduction to prepare you for any type of IV or Agent administration training Types of agents & how to administer
- Challenges and benefits of implementing a sonographer agent administration & IV insertion program
- Pitfalls of IV insertion and solutions
- How to insert an IV
- How to remove an IV
The content of this SDMS CME symposium is intended for healthcare professionals including Sonographers, Imaging Nurses, Administrators, Researchers, and Others.
This program has been submitted for approval of .5 hours of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).
Release Date: 7/29/2024 | Expires 07/28/2025
Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.
Jessica Stout BS, RDCS, FASE
Technical Director, Echocardiography Laboratory, Beth Israel Deaconess Medical Center
